Z. Bloomgarden

发表

Early Life Famine Exposure, Ideal Cardiovascular Health Metrics, and Risk of Incident Diabetes: Findings From the 4C Study

S. Lai, Yu Xu, Weiqing Wang, 2020, Diabetes Care.

Nephropathy and Other Topics

Z. Bloomgarden, 2009, Diabetes Care.

More on Managed Care

Z. Bloomgarden, 1997, Diabetes Care.

Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.

Z. Bloomgarden, W. Futterweit, L. Poretsky, 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Diabetes Association Scientific Sessions, 1995: Neuropathy and Retinopathy

Z. Bloomgarden, 1995, Diabetes Care.

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.

L. Blonde, A. Garber, Z. Bloomgarden, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Review of hemoglobin A1c in the management of diabetes

Z. Bloomgarden, D. Le Roith, E. Gallagher, 2009, Journal of diabetes.

Diabetic nephropathy.

Z. Bloomgarden, 2005, Diabetes care.

International Diabetes Federation Meeting, 1997: Nephropathy, retinopathy, and glycation

Z. Bloomgarden, 1998, Diabetes Care.

A Review of Current Trends in Diabetes

Z. Bloomgarden, 1994, Diabetes Care.

Glycemic Control in Diabetes: A Tale of Three Studies

Z. Bloomgarden, 2008, Diabetes Care.

European Association For The Study Of Diabetes

Z. Bloomgarden, 2002, Diabetologia.

World Congress on the Insulin Resistance Syndrome, 2009

Z. Bloomgarden, 2010, Diabetes Care.

World Congress on the Insulin Resistance Syndrome, 2009

Z. Bloomgarden, 2010, Diabetes Care.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

Irl B Hirsch, Timothy S Bailey, Lois Jovanovič, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.

Paul Zimmet, J. Shaw, P. Zimmet, 2004, Diabetes care.

A1C: Recommendations, Debates, and Questions

Z. Bloomgarden, 2009, Diabetes Care.

The 5th Annual Heart in Diabetes Conference (part 2)

Z. Bloomgarden, 2022, Journal of diabetes.

Diabetes treatment: The coming paradigm shift

Z. Bloomgarden, 2012, Journal of diabetes.

Screening for and managing diabetic retinopathy: current approaches.

Z. Bloomgarden, Zachary T Bloomgarden, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

International Diabetes Federation Meeting, 1997, and Other Recent Meetings: Atherosclerosis and related topics

Z. Bloomgarden, 1998, Diabetes Care.

Insulin resistance: causes and consequences.

Z. Bloomgarden, 2005, International review of neurobiology.

Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.

Z. Bloomgarden, 2004, Diabetes care.

Helping people with diabetes to exercise 帮助糖尿病患者运动

Z. Bloomgarden, Xiaoying Li, 2015, Journal of diabetes.

Angiogenic gene therapy for improving islet graft vascularization

Z. Bloomgarden, Hengjiang Dong, Jennifer, 2004 .

The clinical approach to the detection of lipodystrophy - an AACE consensus statement.

J. Chan, G. Grunberger, R. Henry, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Diabetes and branched‐chain amino acids: What is the link?

Z. Bloomgarden, 2018, Journal of diabetes.

Diabetic Neuropathy

Z. Bloomgarden, 2007, Diabetes Care.

Type 2 Diabetes: Uses of thiazolidinediones and insulin

Z. Bloomgarden, 2011 .

Nonalcoholic Fatty Liver Disease and Insulin Resistance in Youth

Z. Bloomgarden, 2007, Diabetes Care.

Inpatient diabetes control: approaches to treatment.

Z. Bloomgarden, 2004, Diabetes care.

Sodium–glucose cotransporter 2 inhibitors and renal function钠‐葡萄糖共转运体2抑制剂与肾功能

Z. Bloomgarden, 2015, Journal of diabetes.

The 32nd Annual Meeting of the European Association for the Study of Diabetes: Macrovascular disease

Z. Bloomgarden, 1997, Diabetes Care.

Development of diabetic complications despite the absence of growth hormone in a patient with post-pancreatectomy diabetes.

S. Feman, Z. Bloomgarden, D. Rabin, 1984, The New England journal of medicine.

Blood Pressure and Diabetic Nephropathy

Z. Bloomgarden, 2010, Diabetes Care.

Treatment issues in type 1 diabetes.

Z. Bloomgarden, 2002, Diabetes care.

Treatment issues in type 2 diabetes.

Z. Bloomgarden, 2002, Diabetes care.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF HYPERANDROGENIC DISORDERS AACE Hyperandrogenism Guidelines

Keith D. Smith, H. Rodbard, R. Cobin, 2001 .

Glycemic Treatment in Type 1 and Type 2 Diabetes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

Z. Bloomgarden, 2006, Diabetes Care.

American Diabetes Association 60th Scientific Sessions, 2000: glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics.

Z. Bloomgarden, 2001, Diabetes care.

American Diabetes Association 60 th Scientific Sessions , 2000 Glucose tolerance , diabetes and cancer , glycemic control , monitoring , and related topics

Z. Bloomgarden, 2001 .

The American Diabetes Association Annual Meeting, 1994: Treatment Issues fer NIDPM

Z. Bloomgarden, 1994, Diabetes Care.

Summaries of Symposia Conducted in Conjunction with the 19th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists

P. Raskin, R. DeFronzo, I. Hirsch, 2010 .

Fat metabolism and diabetes: 2003 American Diabetes Association postgraduate course.

Z. Bloomgarden, 2003, Diabetes care.

Is haemoglobin A1c a step forward for diagnosing diabetes?

P. Zimmet, E. Kilpatrick, Z. Bloomgarden, 2009, BMJ : British Medical Journal.

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).

G. Breithardt, D. Singer, G. Hankey, 2015, American heart journal.

SGLT-2 INHIBITION ADDED TO GLP-1 AGONIST THERAPY FOR TYPE 2 DIABETES: WHAT IS THE BENEFIT?

Z. Bloomgarden, Y. Handelsman, 2015, Endocrine Practice.

The world congress on insulin resistance, diabetes, and cardiovascular disease (WCIRDC)

Z. Bloomgarden, 2022, Journal of diabetes.

American College of Endocrinology Pre-Diabetes Consensus Conference: Part Two

Z. Bloomgarden, 2008, Diabetes Care.

Bariatric Surgery, Exercise, and Inpatient Glycemia Treatment

Z. Bloomgarden, 2010, Diabetes Care.

Hypertension and Nephropathy

Z. Bloomgarden, 1996, Diabetes Care.

The American Diabetes Association's 57th Annual Advanced Postgraduate Course

Z. Bloomgarden, 2011, Diabetes Care.

Topics in Cardiovascular Disease and Diabetes

Z. Bloomgarden, 1997, Diabetes Care.

Diabetes Treatment and Cardiovascular Safety

Z. Bloomgarden, 2011, Diabetes Care.

International Diabetes Federation Meeting, 1997, and Metropolitan Diabetes Society of New York Meeting, November 1997: Approaches to treatment and other topics in type 1 diabetes; Genetic heterogeneity of diabetes

Z. Bloomgarden, 1998, Diabetes Care.

Diabetic Nephropathy

Z. Bloomgarden, 2008, Diabetes Care.

Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes

Z. Bloomgarden, 2007, Diabetes Care.

Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics

A. McCall, R. Beck, Aaron J. Kowalski, 2018, Diabetes Care.

Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker.

Z. Bloomgarden, W. Futterweit, Arti A Patel, 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Concepts of insulin resistance.

Z. Bloomgarden, 2005, Metabolic syndrome and related disorders.

Non-alcoholic Fatty liver disease and malignancy as complications of insulin resistance.

Z. Bloomgarden, 2005, Metabolic syndrome and related disorders.

The 6th Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2009, Diabetes Care.

Transition from hospital to outpatient diabetes care

Z. Bloomgarden, Y. Handelsman, 2018, Journal of diabetes.

Afrezza: Some questions about a new approach to prandial insulin 关于一种新型餐时胰岛素的一些问题

Z. Bloomgarden, 2014, Journal of diabetes.

Diabetes: The prototypical non‐communicable disease

G. Ning, Z. Bloomgarden, 2012, Journal of diabetes.

Aspects of type 2 diabetes and related insulin-resistant states.

Z. Bloomgarden, 2006, Diabetes care.

Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial

G. Ning, P. Reaven, Z. Bloomgarden, 2020, Diabetes Care.

Adiposity and diabetes.

Z. Bloomgarden, 2002, Diabetes care.

How do we gauge the success of treatment of diabetes?

P. Zimmet, Z. Bloomgarden, 2012, Journal of diabetes.

Conference Report: Renal Disease, Metformin, and the Adipocyte

Z. Bloomgarden, 1996, Diabetes Care.

Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids

Z. Bloomgarden, D. Einhorn, Y. Handelsman, 2011, Journal of diabetes.

Recent cardiovascular trials: What are the drivers of benefit and adverse effect?

Z. Bloomgarden, 2009, Journal of diabetes.

Cardiovascular Disease, Neuropathy, and Retinopathy

Z. Bloomgarden, 2009, Diabetes Care.

American Diabetes Association Annual Meeting, 1998: Cardiac disease and related topics

Z. Bloomgarden, 1998, Diabetes Care.

American College of Endocrinology Pre-Diabetes Consensus Conference: Part Three

Z. Bloomgarden, 2008, Diabetes Care.

American Diabetes Association Annual Meeting, 1997, and the Teczem Consultant Meeting: Diabetic nephropathy

Z. Bloomgarden, 1998, Diabetes Care.

Hypertension in patients with diabetes: questions

Z. Bloomgarden, Ning Guang, 2010, Journal of diabetes.

The Journal of Diabetes: Continuing the dialogue (糖尿病杂志：继续进行对话)

G. Grunberger, Weiqing Wang, G. Ning, 2013, Journal of diabetes.

Chapter 45 – Pearls from Major Clinical Trials: Approaches to Improving Outcome of Persons with Diabetes

Z. Bloomgarden, 2006 .

Diabetes and hypertension.

Z. Bloomgarden, 2001, Diabetes care.

Aspects of blood pressure, lipid, and glycemic treatment.

Z. Bloomgarden, 2004, Diabetes care.

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease

Z. Bloomgarden, 2011, Diabetes Care.

What constitutes good research?

G. Ning, Z. Bloomgarden, 2019, Journal of diabetes.

Journal of Diabetes: Ushering in Volume 10

G. Ning, Z. Bloomgarden, 2018, Journal of diabetes.

Learning from ORIGIN

Z. Bloomgarden, 2012, Journal of diabetes.

Fibrate use in diabetes: New concepts

Z. Bloomgarden, A. Drexler, 2011, Journal of diabetes.

Approaches to cardiovascular disease and its treatment.

Z. Bloomgarden, 2003, Diabetes care.

The European Association for the Study of Diabetes.

Z. Bloomgarden, 2005, Diabetes care.

Diabetes and cancer: Findings from the REACTION study 糖尿病与恶性肿瘤：来自REACTION研究的发现

G. Ning, Z. Bloomgarden, 2015, Journal of diabetes.

Diabetes in China: Prevalence, diagnosis, and control (糖尿病在中国：流行、诊断与控制现状)

G. Ning, Z. Bloomgarden, 2013, Journal of diabetes.

Evolution of type 2 diabetes mellitus treatment approaches

Z. Bloomgarden, 2018, Journal of diabetes.

Approaches to treatment 2: Comparison of American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) type 2 diabetes treatment guidelines

Z. Bloomgarden, Y. Handelsman, 2016, Journal of diabetes.

Diabetes and Obesity

Z. Bloomgarden, 2007 .

What role will 'gliptins' play in glycemic control?

Z. Bloomgarden, A. Drexler, 2008, Cleveland Clinic journal of medicine.

Cancer mortality and insulin glargine

Z. Bloomgarden, Y. Handelsman, 2009, Journal of diabetes.

Insulin resistance in children and in the polycystic ovarian syndrome.

Z. Bloomgarden, 2005, Metabolic syndrome and related disorders.

Diabetes issues in women and children: polycystic ovary syndrome.

Z. Bloomgarden, 2003, Diabetes care.

Diabetes Issues in Women and Children

Z. Bloomgarden, 2003 .

Developments in diabetes and insulin resistance.

Z. Bloomgarden, 2006, Diabetes care.

New insights into the older hypoglycemic agents in type 2 diabetes therapy

Z. Bloomgarden, Min Cao, 2020, Journal of diabetes.

New therapeutic approaches to non-insulin-dependent diabetes mellitus.

Z. Bloomgarden, 1997, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Various and sundry recent publications

Z. Bloomgarden, 2021, Journal of diabetes.

Neuropathy, Retinopathy, and Glucose-Lowering Treatments

Z. Bloomgarden, 2010, Diabetes Care.

The heart in diabetes meeting

Z. Bloomgarden, 2019, Journal of diabetes.

Lower Baseline Glycemia Reduces Apparent Oral Agent Glucose-Lowering Efficacy

C. Viscoli, Z. Bloomgarden, S. Inzucchi, 2006, Diabetes Care.

Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease.

Z. Bloomgarden, 2005, Diabetes care.

Sodium–glucose cotransporter 2 inhibitors and diabetic ketoacidosis

Z. Bloomgarden, 2016, Journal of diabetes.

American Diabetes Association Scientific Sessions, 1995: Nephropathy

Z. Bloomgarden, 1995, Diabetes Care.

American Diabetes Association 60th Scientific Sessions, 2000: thiazolidinediones, obesity, and related topics.

Z. Bloomgarden, 2001, Diabetes care.

Prevention and Treatment of Type 2 Diabetes at a Debate at the Meeting

Z. Bloomgarden, 2022 .

Is insulin the preferred treatment for HbA1c >9%?

Z. Bloomgarden, 2017, Journal of diabetes.

Nonnutritive Sweeteners, Fructose, and Other Aspects of Diet

Z. Bloomgarden, 2011, Diabetes Care.

Diabetes and Aging

G. Ning, Z. Bloomgarden, M. Korytkowski, 2013, Diabetes Spectrum.

Screening children for diabetes: what can ‘low-tech’ accomplish?

Z. Bloomgarden, 2013, Paediatrics and international child health.

Lipids as risk markers for type 2 diabetes

Z. Bloomgarden, R. Chilton, 2019, Journal of diabetes.

COMMENTS AND RESPONSES

E. Kilpatrick, Z. Bloomgarden, Susannah Sherlock, 2008 .

Treatment issues in type 2 diabetes.

Z. Bloomgarden, 2002, Diabetes care.

Hemoglobin A1c in diabetes diagnosis: time for caution.

Z. Bloomgarden, D. Einhorn, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Type 2 treatments for type 1 diabetes

G. Ning, Z. Bloomgarden, 2016, Journal of diabetes.

European Association for the Study of Diabetes Annual Meeting, 1999: the beta-cell, autoimmunity, and insulin resistance.

Z. Bloomgarden, 2000, Diabetes care.

New treatments for diabetes.

Z. Bloomgarden, S. Inzucchi, 2007, The New England journal of medicine.

Potential effects of GLP-1 in type 2 diabetes

Z. Bloomgarden, 2004 .

Gut-derived incretin hormones and new therapeutic approaches.

Z. Bloomgarden, 2004, Diabetes care.

Insulin treatment and type 1 diabetes topics.

Z. Bloomgarden, 2006, Diabetes care.

World Congress on the Insulin Resistance Syndrome, 2009

Z. Bloomgarden, 2010, Diabetes Care.

Paradigm Shift in the management of DM & CVD- Preventing The Next CV Event.

Z. Bloomgarden, Y. Handelsman, 2020, Journal of diabetes.

Which person with diabetes should receive cardioprotective glucose‐lowering medicines?

Z. Bloomgarden, 2020, Journal of diabetes.

Gut hormones and the brain *

G. Ning, Z. Bloomgarden, Y. Handelsman, 2010, Journal of diabetes.

Early‐Life Famine Exposure and Risk of Cardiovascular Diseases in Later Life: Findings From the REACTION Study

R. Zheng, Yu Xu, Weiqing Wang, 2020, Journal of the American Heart Association.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

R. DeFronzo, G. Grunberger, G. Umpierrez, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC☆

Z. Bloomgarden, Y. Handelsman, 2020, American Journal of Preventive Cardiology.

A Diabetes Potpourri, Part 2

Z. Bloomgarden, 1995, Diabetes Care.

Diet and diabetes.

Z. Bloomgarden, 2004, Diabetes care.

Bone Disease, Gestational Diabetes Mellitus, and Health Care

Z. Bloomgarden, 2009, Diabetes Care.

AACE comprehensive diabetes management algorithm 2013.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Talks and tweets from the ADA

Z. Bloomgarden, 2018, Journal of diabetes.

Neuropathy, womens' health, and socioeconomic aspects of diabetes.

Z. Bloomgarden, 2002, Diabetes care.

The European Association for the Study of Diabetes Annual Meeting, 1998. The U.K. Prospective Diabetes Study and other topics in type 2 diabetes.

Z. Bloomgarden, 1999, Diabetes care.

American Diabetes Association Annual Meeting, 1999. New approaches to insulin treatment and glucose monitoring.

Z. Bloomgarden, 1999, Diabetes care.

The Journal of Diabetes in its ninth year

G. Ning, Z. Bloomgarden, 2017, Journal of diabetes.

Questioning glucose measurements used in the International Diabetes Federation (IDF) Atlas

Z. Bloomgarden, 2016, Journal of diabetes.

Association is not causation, particularly with “adjustment” (相关性不是因果关系，特别是“校正过”的相关性)

Z. Bloomgarden, 2014, Journal of diabetes.

Treatment of intractable neonatal hypoglycemia with somatostatin plus glucagon

Z. Bloomgarden, L. Rogers, J. Liljenquist, 1980 .

The Chinese Metabolic Management Centers

Z. Bloomgarden, Jian-ming Liu, 2022, Journal of diabetes.

Incretin Concepts

Z. Bloomgarden, 2010, Diabetes Care.

Implications of the recent CVOTs in Type 2 Diabetes: The right place for DPP-IV inhibitors today.

Z. Bloomgarden, 2019, Diabetes research and clinical practice.

Developments in type 1 and type 2 diabetes

Z. Bloomgarden, 2021, Journal of diabetes.

Use of HbA1c in clinical practice: New insights

Z. Bloomgarden, 2021, Journal of diabetes.

Gut and adipocyte peptides.

Z. Bloomgarden, 2006, Diabetes care.

Sodium‐glucose cotransporter 2 inhibitors for macroalbuminuria: A new indication

Z. Bloomgarden, Y. Handelsman, 2019, Journal of diabetes.

Summary of the ACRE inaugural meeting.

Z. Bloomgarden, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Type 2 diabetes in the young in South Asia: Clinical heterogeneity and need for aggressive public health measures

V. Mohan, Z. Bloomgarden, Anoop Misra, 2021, Journal of diabetes.

Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: Results from a longitudinal cohort and mendelian randomization study

K. Gu, Z. Bloomgarden, Nan Xia, 2022, The Lancet regional health. Western Pacific.

The 2022 American Diabetes Association Meeting

Z. Bloomgarden, 2022, Journal of diabetes.

Diabetic Neuropathy Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

Z. Bloomgarden, 2008, Diabetes Care.

Glycemic treatment: Further concepts

Z. Bloomgarden, 2021, Journal of diabetes.

Is the type of diabetes treatment relevant to outcome of COVID‐19?

Z. Bloomgarden, 2020, Journal of diabetes.

Approaching treatment of the insulin resistance syndrome.

Z. Bloomgarden, 2005, Metabolic syndrome and related disorders.

Insulin treatment of Type 2 diabetes: a clinical perspective

Z. Bloomgarden, Y. Handelsman, A. Drexler, 2010, Journal of diabetes.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.

G. Grunberger, G. Umpierrez, A. Garber, 2018, Endocrine Practice.

Small steps forward: Adjunctive therapy for T1D

Z. Bloomgarden, D. Schatz, 2022, Journal of diabetes.

Cardiovascular safety trials: Be careful what you wish for (心血管安全性研究：当心你许的愿)

G. Grunberger, Z. Bloomgarden, 2014, Journal of diabetes.

American Diabetes Association annual meeting, June 2003: gastrointestinal and dietary aspects of diabetes.

Z. Bloomgarden, 2003, Diabetes care.

American Diabetes Association Annual Meeting, 1997: Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy and erectile dysfunction

Z. Bloomgarden, 1998, Diabetes Care.

Non‐alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control

Z. Bloomgarden, 2017, Journal of diabetes.

Diabetic Nephropathy. Commentaries

Z. Bloomgarden, 2008 .

Individualizing therapy: Do we have the tools to do it? 个体化治疗：我们有具体的执行方法吗？

J. Shaw, Z. Bloomgarden, 2015, Journal of diabetes.

Fournier's gangrene and sodium–glucose cotransporter 2 inhibitors: Is there a causal association?

G. Grunberger, Z. Bloomgarden, D. Einhorn, 2019, Journal of diabetes.

Diabetes: Metformin and renal insufficiency—is 45, or even 30, the new 60?

Z. Bloomgarden, 2015, Nature Reviews Endocrinology.

Diabetes during the COVID‐19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control

Z. Bloomgarden, Anoop Misra, 2020, Journal of diabetes.

American Diabetes Association 60th Scientific Sessions, 2000: diabetes and pregnancy.

Z. Bloomgarden, 2000, Diabetes care.

The New York Diabetes Association's 48th Annual Scientific Meeting, the American Diabetes Association's 48th Annual Advanced Postgraduate Course, and the meeting of the Naomi Berry Diabetes Center of Columbia University.

Z. Bloomgarden, 2001, Diabetes care.

Liraglutide and calcitonin

Z. Bloomgarden, 2010, Journal of diabetes.

Potential mechanisms promoting restenosis in diabetic patients.

Z. Bloomgarden, D. Aronson, E. Rayfield, 1996, Journal of the American College of Cardiology.

Did AIM‐HIGH aim too low?

Z. Bloomgarden, Y. Handelsman, 2012, Journal of diabetes.

Learning by reading: A review of recent diabetes articles

Z. Bloomgarden, 2022, Journal of diabetes.

Type 1 Diabetes and Hypoglycemia

Z. Bloomgarden, 2009, Diabetes Care.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.

K. Wyne, G. Grunberger, A. Garber, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: A post-hoc analysis from SPRINT

Z. Bloomgarden, C. Sheng, Jingyan Tian, 2022, Frontiers in Cardiovascular Medicine.

Abstract 15544: Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis of the ROCKET AF Trial

G. Breithardt, D. Singer, R. Califf, 2012 .

Diabetes and tuberculosis: An important relationship

Z. Bloomgarden, Anoop Misra, 2017, Journal of diabetes.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Irl B Hirsch, Janet B McGill, Lawrence Blonde, 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Diabetes Association Scientific Sessions, 1995: IDDM: Treatment and Prevention

Z. Bloomgarden, 1996, Diabetes Care.

Diabetes complications.

Z. Bloomgarden, Zachary T Bloomgarden, 2004, Diabetes care.

Inflammation and insulin resistance.

Z. Bloomgarden, Zachary T Bloomgarden, 2003, Diabetes care.

Diabetes and nutrition.

Z. Bloomgarden, 2002, Diabetes care.

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

P. Zimmet, E. Kilpatrick, Z. Bloomgarden, 2009, Diabetes Care.

Therapy of Type 2 Diabetes Mellitus

Z. Bloomgarden, 2004 .

The 32nd Annual Meeting of the European Association for the Study of Diabetes: Leptin, insulin resistance, intrauterine malnutrition, sulfonylureas, oral agents alone and with insulin, and new pharmacological approaches to type 2 diabetes

Z. Bloomgarden, 1997, Diabetes Care.

Insulin resistance: current concepts.

Z. Bloomgarden, 1998, Clinical therapeutics.

Obesity, hypertension, and insulin resistance.

Z. Bloomgarden, 2002, Diabetes care.

Cardiovascular disease in type 2 diabetes.

Z. Bloomgarden, 1999, Diabetes care.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.

Irl B Hirsch, Kenneth L Jones, Lois Jovanovič, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Diabetes Association 60th Scientific Sessions, 2000: the diabetic foot.

Z. Bloomgarden, Z T Bloomgarden, 2001, Diabetes care.

American Diabetes Association 60th Scientific Sessions, 2000: cardiovascular disease in diabetes.

Z. Bloomgarden, 2001, Diabetes care.

Diabetes and COVID‐19

Z. Bloomgarden, 2020, Journal of diabetes.

Troubling ethical questions from gestational diabetes trial

Z. Bloomgarden, 2010, Journal of diabetes.

Type 2 diabetes in the young: the evolving epidemic.

Z. Bloomgarden, Zachary T Bloomgarden, 2004, Diabetes care.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF HYPERTENSION AACE Hypertension Task Force AACE Guidelines

Z. Bloomgarden, Joseph J. Torre, 2006 .

Diabetes and cancer relationships (糖尿病与肿瘤的关联性)

G. Ning, Tiange Wang, Z. Bloomgarden, 2013, Journal of diabetes.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Irl B Hirsch, Janet B McGill, Lawrence Blonde, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Iron‐deficiency anemia, non‐iron‐deficiency anemia and HbA1c among adults in the US *

E. Ford, C. Cowie, Chaoyang Li, 2011, Journal of diabetes.

Notes from the world congress on insulin resistance, diabetes, and cardiovascular disease

Z. Bloomgarden, Y. Handelsman, 2019, Journal of diabetes.

2nd International Symposium on Triglycerides and HDL: lipid abnormalities and their treatment.

Z. Bloomgarden, 2005, Diabetes care.

American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes.

Z. Bloomgarden, 2000, Diabetes care.

A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?

Z. Bloomgarden, S. Bansilal, 2016, Journal of the American College of Cardiology.

The future of diabetes.

Z. Bloomgarden, 2015, Canadian journal of diabetes.

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

M. Budoff, R. Eckel, I. D. de Boer, 2021, Journal of diabetes and its complications.

Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults

S. Lai, Jiang He, Yu Xu, 2019, Diabetes Care.

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.

R. Krauss, M. Budoff, K. Wyne, 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary.

Irl B Hirsch, Kenneth L Jones, Lois Jovanovič, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The Jiangnan diet, a healthy diet pattern for Chinese

G. Ning, Xu Lin, Z. Bloomgarden, 2019, Journal of diabetes.

Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary

Yow-Ming C Wang, J. Polli, G. Lyman, 2022, Clinical pharmacology and therapeutics.

Insulin Concerns and Promises

Z. Bloomgarden, 2011, Diabetes Care.

Lessons from glargine trials: What is the goal fasting glucose with basal insulin? (来自甘精胰岛素临床试验的经验教训：使用基础胰岛素治疗的空腹血糖目标是什么？)

Z. Bloomgarden, Y. Handelsman, 2014, Journal of diabetes.

AACE/ACE comprehensive diabetes management algorithm 2015.

J. Garber, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Prevention of Cardiovascular Disease

Z. Bloomgarden, 2007, Diabetes Care.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Eliot A Brinton, Vivian A Fonseca, K. Wyne, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease

Z. Bloomgarden, 2011, Diabetes Care.

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease

Z. Bloomgarden, 2011, Diabetes Care.

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease

Z. Bloomgarden, 2011, Diabetes Care.

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety

Charles E. Leonard, J. Gagne, W. Bilker, 2020, Cardiovascular Diabetology.

The Endocrine Society Meeting: topics in insulin sensitivity and hypertension.

Z. Bloomgarden, 2003, Diabetes care.

American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

J. McGill, I. Hirsch, G. Grunberger, 2013 .

Cardiovascular complications of insulin resistance.

Z. Bloomgarden, 2005, Metabolic syndrome and related disorders.

World Congress on the Insulin Resistance Syndrome, 2009

Z. Bloomgarden, 2010, Diabetes Care.

Approaches to Treatment of Pre-Diabetes and Obesity and Promising New Approaches to Type 2 Diabetes

Z. Bloomgarden, 2008, Diabetes Care.

The American Diabetes Association's 48th Annual Advanced Postgraduate Course.

Z. Bloomgarden, 2001, Diabetes care.

Cardiovascular Disease in Diabetes

Z. Bloomgarden, 2010, Diabetes Care.

Cardiovascular Disease in Diabetes

Z. Bloomgarden, 2008, Diabetes Care.

2nd International Symposium on triglycerides and HDL: metabolic syndrome.

Z. Bloomgarden, 2005, Diabetes care.

Dyslipidemia and the metabolic syndrome.

Z. Bloomgarden, 2004, Diabetes care.

Treatment of type 2 diabetes: the American Association of Clinical Endocrinologists Meeting, May 2002.

Z. Bloomgarden, 2002, Diabetes care.

Diabetes and cancer--an AACE/ACE consensus statement.

J. McGill, C. Hennekens, H. Lebovitz, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

European Association for the Study of Diabetes Annual Meeting, 2000: Pathogenesis of type 2 diabetes, vascular disease, and neuropathy.

Z. Bloomgarden, 2001, Diabetes care.

Inflammation, atherosclerosis, and aspects of insulin action.

Z. Bloomgarden, 2005, Diabetes care.

Second World Congress on the Insulin Resistance Syndrome: hypertension, cardiovascular disease, and treatment approaches.

Z. Bloomgarden, 2005, Diabetes care.

Second World Congress on the Insulin Resistance Syndrome: mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy.

Z. Bloomgarden, 2005, Diabetes care.

American Diabetes Association Annual Meeting, 1999

Z. Bloomgarden, 2000 .

American College of Endocrinology Pre-Diabetes Consensus Conference: Part Two

Z. Bloomgarden, 2008, Diabetes Care.

New insights in obesity.

Z. Bloomgarden, 2002, Diabetes care.

Atypical Antipsychotic Agents, Retinopathy, Nephropathy, and Cardiovascular Disease

Z. Bloomgarden, 2006, Diabetes Care.

Diabetic Retinopathy and Diabetic Neuropathy

Z. Bloomgarden, 2007, Diabetes Care.

American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.

Z. Bloomgarden, 2003, Diabetes care.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

I. Hirsch, G. Grunberger, G. Umpierrez, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.

Z. Bloomgarden, 2003, Diabetes care.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension.

Z. Bloomgarden, M. Hogan, R. A. Dickey, 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Discordance between HbA1c and glycemia

Z. Bloomgarden, Anoop Misra, 2018, Journal of diabetes.

Hypertension in Diabetes: Treatment Considerations

Z. Bloomgarden, Mariela Glandt, 2011, Journal of clinical hypertension.

Does A1c consistently reflect mean plasma glucose?

D. Shrom, Z. Bloomgarden, S. Sarwat, 2010, Journal of diabetes.

Type 1 Diabetes and Glucose Monitoring

Z. Bloomgarden, 2007, Diabetes Care.

Cardiovascular Disease Zachary T. Bloomgarden, MD, is a practicing endocrinologist in New York, New York, and is affiliated with the Division of Endocrinology, Mount Sinai School of Medicine, New York, New York.

Z. Bloomgarden, 2006, Diabetes Care.

The epidemiology of complications.

Z. Bloomgarden, 2002, Diabetes care.

American Diabetes Association 60th Scientific Sessions, 2000. Nephropathy.

Z. Bloomgarden, 2001, Diabetes care.

Third Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2006, Diabetes Care.

Medical writer

Kenneth L. Jones, H. Lebovitz, G. Grunberger, 2019, Combatting Burnout.

Third Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2006, Diabetes Care.

Diabetes and Obesity

Z. Bloomgarden, 2007, Diabetes Care.

American Diabetes Association Postgraduate Meetings—2011

Z. Bloomgarden, 2011, Diabetes Care.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

J. Garber, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Sugar‐sweetened beverages: Changing the tide (含糖饮料：潮流的改变)

Z. Bloomgarden, Y. Handelsman, 2013, Journal of diabetes.

Topics in Type 2 Diabetes

Z. Bloomgarden, 1997, Diabetes Care.

Comparative Safety of Dipeptidyl Peptidase‐4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population‐Based Cohort Studies

Charles E. Leonard, W. Bilker, C. Brensinger, 2021, Clinical pharmacology and therapeutics.

Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.

S. Lai, Yu Xu, Weiqing Wang, 2019, JAMA cardiology.

The kidney and cardiovascular outcome trials

Z. Bloomgarden, 2018, Journal of diabetes.

Diabetes and stroke: An important complication

Z. Bloomgarden, R. Chilton, 2020, Journal of diabetes.

Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add‐ons to metformin: A retrospective cohort database study

Z. Bloomgarden, K. Tunceli, V. Fonseca, 2017, Journal of diabetes.

Basal insulin or longacting GLP-1 receptor agonists-making the right choice.

Z. Bloomgarden, 2014, The Lancet Diabetes and Endocrinology.

Diabetes: East meets West. The Joint American Association of Clinical Endocrinologists‐Chinese Society of Endocrinology (AACE‐CSE) Symposium

Z. Bloomgarden, 2012, Journal of diabetes.

Sodium glucose transporter 2 inhibition: A new approach to diabetes treatment (抑制钠葡萄糖转运体2：一种新的糖尿病治疗方法)

Z. Bloomgarden, 2013, Journal of diabetes.

Studying and learning

Z. Bloomgarden, 2023, Journal of diabetes.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.

G. Bray, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Approaches to Treatment of Type 2 Diabetes

Z. Bloomgarden, 2008, Diabetes Care.

The Avandia Debate

Z. Bloomgarden, 2007, Diabetes Care.

Measures of insulin sensitivity.

Z. Bloomgarden, 2006, Clinics in laboratory medicine.

Hypoglycemia in Type 2 Diabetes: Current Controversies and Changing Practices

Z. Bloomgarden, D. Einhorn, 2012, Front. Endocrin..

Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.

Z. Bloomgarden, Y. Handelsman, M. Kosiborod, 2017, Journal of the American College of Cardiology.

Cardiovascular disease and diabetes.

Z. Bloomgarden, 2003, Diabetes care.

Diabetes and Obesity

Z. Bloomgarden, 2007, Diabetes Care.

Determinants of adherence to diabetes treatment

Z. Bloomgarden, A. Stevens, A. Larkin, 2015, Journal of diabetes.

Metabolic memory: Evolving concepts

Z. Bloomgarden, Anoop Misra, Zachary Bloomgarden, 2018, Journal of diabetes.

Da Qing, Finnish DPP, Tripod, and Dream: Lifestyle and Thiazolidinediones in the Prevention of Diabetes

Z. Bloomgarden, Mariela Glandt, 2012 .

Temporal trends in ischemic stroke and anticoagulation therapy for non‐valvular atrial fibrillation: effect of diabetes

J. Halperin, C. Herzog, C. Solid, 2017, Journal of diabetes.

Prevention of obesity and diabetes.

Z. Bloomgarden, 2003, Diabetes care.

The Kidney and CVOTs

Z. Bloomgarden, 2017 .

American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia

G. Grunberger, A. Garber, Z. Bloomgarden, 2018, Journal of Diabetes.

Is HbA1c 65 Years Old

Z. Bloomgarden, D. Einhorn, Y. Handelsman, 2017 .

Sleep duration and snoring associate with hypertension and glycaemic control in patients with diabetes

T. Yang, G. Ning, Y. Bi, 2015, Diabetic medicine : a journal of the British Diabetic Association.

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease

Z. Bloomgarden, 2011, Diabetes Care.

Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study (队列简介：中国糖尿病患者肿瘤发生风险的纵向研究（REACTION研究）)

Zhen Ye, Zhengnan Gao, Tao Yang, 2014, Journal of diabetes.

Diabetes trends in youth

Z. Bloomgarden, R. Rapaport, Zachary Bloomgarden, 2023, Journal of diabetes.

Gestational Diabetes Mellitus and Obesity

Z. Bloomgarden, 2010, Diabetes Care.

Supplements

Z. Bloomgarden, 2018, Journal of diabetes.

Presentations at the 81st scientific sessions of the American Diabetes Association, part 2

Z. Bloomgarden, 2021, Journal of diabetes.

Beyond HbA1c, second take

Z. Bloomgarden, 2019, Journal of diabetes.

An evaluation of diabetes self-management applications for Android smartphones

Ronald Tamler, R. Tamler, Z. Bloomgarden, 2012, Journal of telemedicine and telecare.

Diabetes and Cardiovascular Disease

Z. Bloomgarden, 2011, Diabetes Care.

Obesity and diabetes.

Z. Bloomgarden, 2000, Diabetes care.

Beyond HbA1c

Z. Bloomgarden, 2017, Journal of diabetes.

Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis

Z. Bloomgarden, A. Singh, Anoop Misra, 2023, Journal of diabetes.

Treatment: Concepts and new developments

Z. Bloomgarden, A. Drexler, 2016, Journal of diabetes.

2009 World Congress on the Insulin Resistance Syndrome: Cardiovascular Disease Concepts

Z. Bloomgarden, 2010, Diabetes Care.

The potential of β‐cell growth promotion, continued

Z. Bloomgarden, 2023, Journal of Diabetes.

Novel approaches to the treatment of type 1 diabetes

Z. Bloomgarden, 2022, Journal of diabetes.

The Fifth Annual Heart in Diabetes Conference (Part 1)

Z. Bloomgarden, 2021, Journal of diabetes.

The Diabetic Foot

Z. Bloomgarden, Zachary T Bloomgarden, 2008, Diabetes Care.

European Association for the Study of Diabetes (EASD) 2001 meeting.

Z. Bloomgarden, 2002, Diabetes care.

Diabetic retinopathy and neuropathy.

Z. Bloomgarden, 2005, Diabetes care.

Insulin Resistance, Dyslipidemia, and Cardiovascular Disease

Z. Bloomgarden, 2007, Diabetes Care.

Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old?

Z. Bloomgarden, D. Einhorn, Y. Handelsman, 2017, Diabetes Care.

Insulin Resistance Concepts

Z. Bloomgarden, 2007, Diabetes Care.

The proposed terminology ‘A1c-derived average glucose’ is inherently imprecise and should not be adopted

Z. T. Bloomgarden, S. E. Inzucchi, E. Karnieli, 2008, Diabetologia.

How can we reach the target of glucose control in type 1 diabetes?

Z. Bloomgarden, 2023, Journal of diabetes.

Hypoglycemia in the intensive care unit

J. Mechanick, Z. Bloomgarden, Y. Handelsman, 2007, Current opinion in clinical nutrition and metabolic care.

Upper extremity arthropathy in diabetes

Z. Bloomgarden, 2017, Journal of diabetes.

Transplantation and islet topics.

Z. Bloomgarden, 2005, Diabetes care.

Third Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2006, Diabetes Care.

Celiac disease: A global survey

Z. Bloomgarden, R. Rapaport, 2021, Journal of diabetes.

Diabetes Treatment

Z. Bloomgarden, 2009, Diabetes Care.

Reduced Kidney Function Is Associated With Cardiometabolic Risk Factors, Prevalent and Predicted Risk of Cardiovascular Disease in Chinese Adults: Results From the REACTION Study

S. Lai, Yu Xu, Weiqing Wang, 2016, Journal of the American Heart Association.

Pharmacologic treatment of type 2 diabetes.

Z. Bloomgarden, Zachary T Bloomgarden, 2003, Diabetes care.

Biosimilar insulin concepts

Z. Bloomgarden, 2022, Journal of diabetes.

Exploring Treatment Strategies for Type 2 Diabetes

Z. Bloomgarden, 2007, Diabetes Care.

Diabetes treatment over age 65: Is worse control really better?

Z. Bloomgarden, D. Einhorn, Y. Handelsman, 2017, Journal of diabetes.

Inpatient diabetes control: rationale.

Z. Bloomgarden, 2004, Diabetes care.

Final “Perspectives on the News”

Z. Bloomgarden, 2011, Diabetes Care.

Rationale for glycemic control to improve cardiovascular outcome: Lessons from east and west

J. Chan, Z. Bloomgarden, 2021, Journal of diabetes.

Is glycemic control a quinidine‐like intervention? 控制血糖与使用奎尼丁治疗一样吗？

Z. Bloomgarden, 2014, Journal of diabetes.

The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations.

L. Blonde, A. Garber, Z. Bloomgarden, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Does glycemic control affect outcome of COVID‐19?

Z. Bloomgarden, 2020, Journal of diabetes.

American Diabetes Association Scientific Sessions, 1995: Non-insulin-dependent diabetes mellitus

Z. Bloomgarden, 1995, Diabetes Care.

American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes.

G. Bray, P. Wilson, E. Ford, 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The 1st World Congress on the Insulin Resistance Syndrome.

Z. Bloomgarden, 2004, Diabetes care.

ADA2019

Z. Bloomgarden, 2019, Journal of diabetes.

A diabetes update

Z. Bloomgarden, 2023, Journal of diabetes.

European Association for the Study of Diabetes Annual Meeting, 1999: complications of diabetes.

Z. Bloomgarden, 1999, Diabetes care.

Glycemic treatment: Control of glycemia.

Z. Bloomgarden, 2004, Diabetes care.

Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.

S. Lai, R. Zheng, Yu Xu, 2023, Diabetes & metabolism.

The Avandia debate: An unhappy conclusion

Z. Bloomgarden, Y. Handelsman, 2010, Journal of diabetes.

Cardiovascular Disease and Glycemic Treatment

Z. Bloomgarden, 2010, Diabetes Care.

What is the evidence base for the randomized controlled trial?

G. Ning, Z. Bloomgarden, 2009, Journal of diabetes.

Diabetic Retinopathy

Z. Bloomgarden, 2008, Diabetes Care.

The long-term benefi ts of lifestyle interventions for prevention of diabetes

Z. Bloomgarden, 2014 .

American Diabetes Association Annual Meeting, 1997: Improvement of the quality of diabetes care

Z. Bloomgarden, 1998, Diabetes Care.

AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

H. Gharib, D. Duick, J. Garber, 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American association of clinical endocrinologists meeting, may 2002.

Z. Bloomgarden, 2002, Diabetes care.

Prevention of Microvascular Complications of Diabetes

Z. Bloomgarden, A. Gouller, 2004 .

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

H. Rodbard, N. Watts, R. Recker, 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.

H. Rodbard, N. Watts, R. Recker, 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The 6th Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2009, Diabetes Care.

Response to Comment on Bloomgarden et al. Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old? Diabetes Care 2017;40:526–528

Z. Bloomgarden, D. Einhorn, Y. Handelsman, 2017, Diabetes Care.

European Association for the Study of Diabetes Annual Meeting, 2000: Pathogenesis of type 2 diabetes, vascular disease, and neuropathy.

Z. Bloomgarden, 2001, Diabetes care.

The W orld C ongress of I nsulin R esistance, D iabetes and C ardiovascular

~~Z. Bloomgarden, 2023, Journal of Diabetes.~~

The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

Z. Bloomgarden, 2023, Journal of diabetes.

Obesity: Mediators and Treatment Approaches

Z. Bloomgarden, 2009, Diabetes Care.

Aspects of Insulin Treatment

Z. Bloomgarden, 2010, Diabetes Care.

Fear of hypoglycemia

Z. Bloomgarden, 2017, Journal of diabetes.

American Diabetes Association Annual Meeting, 1998. Insulin resistance, exercise, and obesity.

Z. Bloomgarden, 1999, Diabetes care.

Prevention of Cardiovascular Disease

Z. Bloomgarden, 2007, Diabetes Care.

The 6th Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2009, Diabetes Care.

Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary

Yow-Ming C Wang, J. Polli, G. Lyman, 2022, Clinical Pharmacology & Therapeutics.

Supplements

Z. Bloomgarden, Zachary Bloomgarden, 2018, Journal of diabetes.

Glycemic control and the heart: it matters how you get there

Z. Bloomgarden, 2016, Journal of diabetes.

Diabetes in youth: A dilemma of pathogenesis

Z. Bloomgarden, Y. Handelsman, 2011, Journal of diabetes.

American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for Action

C. Hudis, T. Powell-Wiley, W. Demark-Wahnefried, 2017, Obesity.

Dipeptidyl peptidase‐4 inhibitor approaches

Z. Bloomgarden, 2017, Journal of diabetes.

Sugar‐sweetened beverages: Changing the tide (含糖饮料：潮流的改变)

Z. Bloomgarden, Y. Handelsman, Zachary Bloomgarden Editor-in-Chief, 2013, Journal of diabetes.

Hypertension in Diabetes: Treatment Considerations

Z. Bloomgarden, Mariela Glandt, 2011, Journal of clinical hypertension.

Does A1c consistently reflect mean plasma glucose?

D. Shrom, Z. Bloomgarden, S. Sarwat, 2010, Journal of diabetes.

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Kenneth L. Jones, H. Lebovitz, G. Grunberger, 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Role of glucagon in treating diabetes: Evidence and concepts (胰高血糖素在糖尿病治疗中的作用：证据与概念)

Z. Bloomgarden, 2014, Journal of diabetes.

Gut hormones and the brain *

G. Ning, Z. Bloomgarden, Y. Handelsman, 2010, Journal of diabetes.

Non-alcoholic Fatty liver disease and malignancy as complications of insulin resistance.

Z. Bloomgarden, 2005, Metabolic syndrome and related disorders.

Clinical diabetic neuropathy.

Z. Bloomgarden, 2005, Diabetes care.

American Diabetes Association annual meeting, 1999: nephropathy and neuropathy.

Z. Bloomgarden, 1999, Diabetes care.

Edinburgh Research Explorer Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation

G. Breithardt, D. Singer, G. Hankey, 2017 .

Efficacy and Safety of Rivaroxaban in Patients with Diabetes and Nonvalvular Atrial Fibrillation : The ROCKET AF Trial

Keith, G. Breithardt, D. Singer, 2015 .

Helping people with diabetes to exercise 帮助糖尿病患者运动

Z. Bloomgarden, Xiaoying Li, 2015, Journal of diabetes.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

H. Rodbard, N. Watts, R. Recker, 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The 6th Annual World Congress on the Insulin Resistance Syndrome

Z. Bloomgarden, 2009, Diabetes Care.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

G. Bray, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Consequences of diabetes: cardiovascular disease.

Z. Bloomgarden, 2004, Diabetes care.

Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old?

Z. Bloomgarden, D. Einhorn, Y. Handelsman, 2017, Diabetes Care.

Pulmonary disease in diabetes

Z. Bloomgarden, 2023, Journal of diabetes.

Cardiovascular complications of insulin resistance.

Z. Bloomgarden, 2005, Metabolic Syndrome and Related Disorders.

Cardiovascular disease.

Z. Bloomgarden, 2006, Diabetes care.

American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine Practice.

Association Between Age at Diabetes Diagnosis and Subsequent Incidence of Cancer: A Longitudinal Population-Based Cohort

Z. Bloomgarden, Jingyan Tian, M. Cheng, 2024, Diabetes care.

Chelation for diabetes complications: A neglected approach?

Z. Bloomgarden, 2017, Journal of diabetes.

Cancer mortality and insulin glargine

Z. Bloomgarden, Y. Handelsman, 2009, Journal of diabetes.

Thiazolidinediones.

Z. Bloomgarden, 2005, Diabetes care.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

R. DeFronzo, G. Grunberger, G. Umpierrez, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Glucokinase and the potential of glucokinase activation in type 2 diabetes

Z. Bloomgarden, 2019, Journal of diabetes.

American Diabetes Association Annual Meeting 1996: The Etiology of Type II Diabetes, Obesity, and the Treatment of Type II Diabetes

Z. Bloomgarden, 1996, Diabetes Care.

The WCIRDC 2023: Concepts of insulin resistance

Z. Bloomgarden, 2024, Journal of diabetes.